CJC-1295 DAC

$50.00

CJC-1295 DAC is a long-acting GHRH analog that provides sustained growth hormone stimulation, supporting fat loss, muscle preservation, deep tissue repair, anti-aging benefits, and metabolic improvements with reduced injection frequency for advanced regenerative research protocols.

Add $350.00 to cart and get free shipping!

In stock

Category:
Description

Buy CJC-1295 DAC Peptide for Sale

Product Specifications

Category Details
Peptide Name CJC-1295 DAC (Drug Affinity Complex)
Purity 99%+ pharmaceutical grade
Available Vial Size 2mg vials
Molecular Formula C165H271N47O46
Molecular Weight 3647 g/mol
Administration Subcutaneous injection (research use only)
Storage Store refrigerated at 2-8°C

What is CJC-1295 DAC?

CJC-1295 DAC (Drug Affinity Complex) is a long-acting analog of growth hormone-releasing hormone (GHRH) designed to significantly extend the half-life of growth hormone stimulation. In research models, CJC-1295 DAC allows for continuous, elevated growth hormone release for several days following a single dose, making it highly effective for long-term regenerative, anti-aging, fat loss, and muscle preservation studies.

Unlike CJC-1295 without DAC, which produces short bursts of GH, the DAC version provides a sustained, steady GH elevation, making it useful for certain advanced research applications.

How Does CJC-1295 DAC Work?

CJC-1295 DAC binds to albumin in the bloodstream, extending its half-life up to 8 days, allowing for fewer injections while maintaining stable GH elevation. Its mechanisms include:

  • Sustained stimulation of pituitary GH secretion

  • Continuous fat metabolism and improved body composition

  • Muscle preservation and lean tissue repair

  • Enhanced tissue regeneration and recovery

  • Improvement of skin elasticity and anti-aging markers

  • Deeper sleep quality and overall hormonal optimization

Its long-acting profile allows researchers to study extended growth hormone elevation without frequent administration.

CJC-1295 DAC Benefits

  • Prolonged growth hormone elevation with fewer injections

  • Promotes fat loss and lean muscle retention

  • Supports deep tissue repair and recovery

  • Improves metabolic function and insulin sensitivity

  • Enhances skin elasticity and anti-aging effects

  • Supports better sleep and neurological repair

  • Long-term regenerative and longevity applications

CJC-1295 DAC Dosage (Research Purposes Only)

  • Standard Dosage: 2mg once weekly

  • Alternate Protocols: Some protocols use 2mg every 3–5 days depending on research design

  • Cycle Length: 8–12 weeks or longer depending on study length

  • Administration: Subcutaneous injection

CJC-1295 DAC is often combined with Ipamorelin or GHRPs for synergistic GH release patterns.

Potential Side Effects

CJC-1295 DAC is generally well-tolerated, though some research models report:

  • Injection site irritation or mild swelling

  • Temporary flushing or tingling sensation post-injection

  • Water retention or mild edema (dose-dependent)

  • Occasional headaches or joint stiffness

Gradual dosing protocols typically minimize side effect risks.

Why Researchers Buy CJC-1295 DAC from AnabolicPharm

AnabolicPharm supplies pharmaceutical-grade CJC-1295 DAC, fully lab-tested for purity, stability, and consistent peptide integrity. Researchers trust AnabolicPharm for reliable, professional-grade peptides used in advanced growth hormone studies, fat loss research, anti-aging models, and long-term regenerative protocols.

Every vial is manufactured under strict quality controls and shipped with full transparency, fast delivery, and professional handling for serious research applications.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 DAC”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.